A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...

In a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS ...

The battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and Wegovy ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Engel started taking Ozempic in August 2023 ... Food and Drug Administration for the treatment of diabetes and chronic kidney disease. However, it is often prescribed or used for weight loss.

Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 - covering burden, and the value of treatment and prevention ...

Chronic kidney disease (CKD) is when the kidneys are permanently ... of kidney disease progression Reduced risk of kidney failure Ozempic is currently the only GLP-1 medication the FDA has ...

Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but sometimes, that's not enough.

A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...